Linda Rhodes
2014
In 2014, Linda Rhodes earned a total compensation of $1.1M as Chief Scientific Officer at Aratana Therapeutics, a 215% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $122,906 |
|---|---|
| Option Awards | $672,826 |
| Salary | $321,923 |
| Other | $10,400 |
| Total | $1,128,055 |
Rhodes received $672.8K in option awards, accounting for 60% of the total pay in 2014.
Rhodes also received $122.9K in non-equity incentive plan, $321.9K in salary and $10.4K in other compensation.
Rankings
In 2014, Linda Rhodes' compensation ranked 7,053rd out of 13,032 executives tracked by ExecPay. In other words, Rhodes earned more than 45.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,053 out of 13,032 | 46th |
Division Manufacturing | 2,592 out of 4,965 | 48th |
Major group Chemicals And Allied Products | 880 out of 1,690 | 48th |
Industry group Drugs | 693 out of 1,369 | 49th |
Industry Pharmaceutical Preparations | 530 out of 1,042 | 49th |
Source: SEC filing on April 28, 2015.
Rhodes' colleagues
We found four more compensation records of executives who worked with Linda Rhodes at Aratana Therapeutics in 2014.